Advertisement

Topics

Proneuron Biotechnologies Company Profile

11:04 EST 10th December 2018 | BioPortfolio

Proneuron Biotechnologies is a biopharmaceutical company developing therapies for neurological disorders, including spinal cord injuries (SCI), brain trauma, and neurodegenerative diseases such as ALS, Huntington’s and Alzheimer’s diseases. The brain, spinal cord and optic nerves comprise the central nervous system (CNS) one of the most complex and enigmatic systems in nature. The CNS is responsible for consciousness, memory, intelligence, the five senses, and controlled movement. However, these functions may be disrupted by brain damage, spinal injury or disease, causing severe disability, such as paralysis, blindness, or loss of mental capabilities. The disability is often permanent because the CNS has a very limited capacity for healing and self repair.While there is no paralysis cure yet available to treat spinal cord injury, nor any cure for CNS trauma in general, scientists at the Weizmann Institute of Science and Proneuron have demonstrated that CNS recovery may be enhanced by applying the body’s own repair system, the immune system, which is actively involved in wound-healing in other parts of the body. In the quest for a paralysis cure, Proneuron is pursuing an aggressive research and development program based on proprietary immune-modulating technology. Proneuron's lead product is ProCord, an experimental cell therapy that is being developed to treat acute spinal cord injury. Besides spinal cord injuries, additional products are being developed for other debilitating neurological indications

Location

Weizmann Science Park, Building 14,P.O.B. 277
Ness-Ziona
74101
Israel

Contact

Phone: 972-8-9409550
Fax: 972-8-9409560
Email: information@proneuron.com


News Articles [128 Associated News Articles listed on BioPortfolio]

DGAP-Stimmrechte: Elanix Biotechnologies AG (deutsch)

Elanix Biotechnologies AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung DGAP Stimmrechtsmitteilung: Elanix Biotechnologies AG Elanix Biotechnologies AG: Veröf...

DGAP-Gesamtstimmrechtsmitteilung: Elanix Biotechnologies AG (deutsch)

Elanix Biotechnologies AG: Veröffentlichung der Gesamtzahl der Stimmrechte nach § 41 WpHG mit dem Ziel der europaweiten Verbreitung DGAP Gesamtstimmrechtsmitteilung: Elanix Biotechnologies AG / Ve.....

Deals this week: SQZ Biotechnologies, Immugenyx, Berkeley Lights

SQZ Biotechnologies has expanded its collaboration with Roche to develop products for oncology indications using cellular therapy. The two companies...Read More... The post Deals this week: SQZ Biotec...

DGAP-Adhoc: Elanix Biotechnologies AG: Widerruf der Bestellung von Herrn Tomas J. Svoboda (CEO) als Vorstandsmitglied (deutsch)

Elanix Biotechnologies AG: Widerruf der Bestellung von Herrn Tomas J. Svoboda (CEO) als Vorstandsmitglied DGAP-Ad-hoc: Elanix Biotechnologies AG / Schlagwort(e): Personalie Elanix Biotechnologies A...

DGAP-Adhoc: Elanix Biotechnologies AG: Frau Professor Laurent-Applegate, Gründerin und Interims-Vorstand, kündigt Verkauf von Aktien der Elanix Biotechnologies AG an (deutsch)

Elanix Biotechnologies AG: Frau Professor Laurent-Applegate, Gründerin und Interims-Vorstand, kündigt Verkauf von Aktien der Elanix Biotechnologies AG an DGAP-Ad-hoc: Elanix Biotechnologies AG / Sc....

INVITROGEN MOTHER E-BASE BY ETHROG BIOTECHNOLOGIES

$35.00End Date: Friday Aug-3-2018 5:25:47 PDTBuy It Now for only: $35.00Buy It Now | Add to watch list Biotech365 : INVITROGEN MOTHER E-BASE BY ETHROG BIOTECHNOLOGIES BioMarketplace You want to p...

Elanix Biotechnologies: Erfolgreiche Finanzierungsrunde

Ende Mai hat Elanix Biotechnologies eine Kapitalerhöhung angekündigt, heute kommt die Vollzugsmeldung der Berliner. Die Gesellschaft hat fast 0,68 Millionen Aktien ausgegeben. Der Bezugspreis je Ak....

Hoverink Biotechnologies, Inc., today announced that they have completed an application with the USPTO for MAXKAFLEN®. Hoverink Biotechnologies, Inc plans to develop and commercialize MAXKAFLEN® a cattle and swine antibiotic.

Overview LOS ANGELES, CA, Nov. 12, 2018 (GLOBE NEWSWIRE) -- On September 26, 2018 We filed trademark applications covering: MAXKAFLEN® Word Mark               MAXKAFLEN Goods and...

Drugs and Medications [0 Results]

None

PubMed Articles [15 Associated PubMed Articles listed on BioPortfolio]

Biological sulfur oxidation in wastewater treatment: A review of emerging opportunities.

Sulfide prevails in both industrial and municipal waste streams and is one of the most troublesome issues with waste handling. Various technologies and strategies have been developed and used to deal ...

High-throughput optimisation of light-driven microalgae biotechnologies.

Microalgae biotechnologies are rapidly developing into new commercial settings. Several high value products already exist on the market, and systems development is focused on cost reduction to open up...

Integrating Proteins in Layer-by-Layer Assemblies Independently of their Electrical Charge.

Layer-by-layer (LbL) assembly is an attractive method for proteins immobilization at interfaces, a much wanted step for e.g. biotechnologies and biomedicine. Integrating proteins in LbL thin films is ...

Enhancing Yeast Alcoholic Fermentations.

The production of ethanol by yeast fermentation represents the largest of all global biotechnologies. Consequently, the yeast Saccharomyces cerevisiae is the world's premier industrial microorganism, ...

Preparation of magnetic microspheres functionalized by lanthanide oxides for selective isolation of bovine hemoglobin.

The isolation and depletion of highly-abundant proteins and peptides is of vital importance for the screening and monitoring of biomarkers which are low stoichiometry in proteomics and protein-based b...

Clinical Trials [0 Results]

None

Companies [105 Associated Companies listed on BioPortfolio]

Proneuron Biotechnologies (Israel) Limited

Proneuron Biotechnologies is developing therapies for neurological, ophthalmologic and immune-related disorders such as spinal cord injuries, multiple sclerosis, glaucoma, Parkinson's disease and Alzh...

Proneuron Biotechnologies

Proneuron Biotechnologies is a biopharmaceutical company developing therapies for neurological disorders, including spinal cord injuries (SCI), brain trauma, and neurodegenerative diseases such as ALS...

RAN Biotechnologies

Based in Beverly, MA, USA, RAN Biotechnologies, Inc., www.ranbiotechnologies.com, provides chemicals specially optimized for microfluidic and biotechnological applications. Partic...

Open Therapeutics

Open Therapeutics (http://OpenTherapeutics.org) is a crowdsourcing life science firm that creates and attracts therapeutic biotechnologies and crowdsources them for the global ...

Genemed Biotechnologies Incorporated

Genemed Biotechnologies Inc. provides high quality contract manufacturing services for a wide variety of research and diagnostic products including native or recombinant proteins and nucleotides

More Information about "Proneuron Biotechnologies" on BioPortfolio

We have published hundreds of Proneuron Biotechnologies news stories on BioPortfolio along with dozens of Proneuron Biotechnologies Clinical Trials and PubMed Articles about Proneuron Biotechnologies for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Proneuron Biotechnologies Companies in our database. You can also find out about relevant Proneuron Biotechnologies Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Spinal Cord Disorders
The spinal cord is a bundle of nerves that runs down the middle of the back which carry signals back and forth between the body and brain. It is protected by vertebrae, which are the bone disks that make up the spine. An accident that damages the verte...


Corporate Database Quicklinks



Searches Linking to this Company Record